Seqens
Seqens, officially known as Seqens S.A., is a leading player in the pharmaceutical and fine chemicals industry, headquartered in France. Established in 2017, Seqens has rapidly expanded its operations across Europe, North America, and Asia, positioning itself as a key partner for major pharmaceutical companies. The company specialises in the development and manufacturing of active pharmaceutical ingredients (APIs) and advanced intermediates, offering unique solutions that cater to the evolving needs of the market. With a strong focus on innovation and sustainability, Seqens has achieved significant milestones, including the establishment of several state-of-the-art production facilities. Recognised for its commitment to quality and regulatory compliance, Seqens has solidified its market position, serving a diverse clientele and contributing to advancements in healthcare. Its dedication to excellence and customer satisfaction sets Seqens apart in a competitive landscape.
DitchCarbon Score
How does Seqens's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Seqens's score of 28 is higher than 97% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Seqens's reported carbon emissions
In 2023, Seqens reported total greenhouse gas emissions of approximately 268,844,000 kg CO2e, comprising 65,556,000 kg CO2e from Scope 1 and 203,288,000 kg CO2e from Scope 2. The company has not disclosed Scope 3 emissions for this year, but in 2021, they reported Scope 3 emissions of about 2,037,180,000 kg CO2e. Seqens has set ambitious near-term targets to significantly reduce its carbon footprint. The company commits to a 46.2% reduction in absolute Scope 1 and 2 greenhouse gas emissions by 2031, using 2021 as the base year. Additionally, Seqens aims for a 27.5% reduction in absolute Scope 3 emissions within the same timeframe. These targets align with the Science Based Targets initiative (SBTi) and are designed to support global efforts to limit temperature rise to 1.5°C. Overall, Seqens is actively working towards reducing its carbon emissions and enhancing its sustainability practices within the chemicals sector, demonstrating a commitment to addressing climate change.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | - | - | - | - | - | - | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | - | - | - | - | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - | - | - | 0,000,000,000 | - | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Seqens is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
